Activity of posaconazole and other antifungal agents against mucorales strains identified by sequencing of internal transcribed spacers

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 4, 2009, Pages 1686-1689

  Alastruey Izquierdo, Ana ^a   Victoria Castelli, Maria ^a   Cuesta, Isabel ^a   Monzón, Arace H ^a   Cuenca Estrella, Manuel ^a   Rodriguez Tudela, Juan Luis ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; POSACONAZOLE; RAVUCONAZOLE; TERBINAFINE; VORICONAZOLE;

AMINO ACID SEQUENCE; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; APOPHYSOMYCES; ARTICLE; CUNNINGHAMELLA; CUNNINGHAMELLA BERTHOLLETIAE; DRUG ACTIVITY; FUNGAL STRAIN; GEOMETRY; MINIMUM INHIBITORY CONCENTRATION; MUCOR CIRCINELLOIDES; MUCORALES; NONHUMAN; PRIORITY JOURNAL; RHIZOMUCOR VARIABILIS; RHIZOPUS ORYZAE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DNA, RIBOSOMAL SPACER; MICROBIAL SENSITIVITY TESTS; MUCORALES; TRIAZOLES;

EID: 65649091750     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01467-08     Document Type: Article

References (30)

1. Aberkane, A., M. Cuenca-Estrella, A. Gomez-Lopez, E. Petrikkou, E. Mellado, A. Monzón, et al. 2002. Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi. J. Antimicrob. Chemother. 50:719-722.
2. Alastruey-Izquierdo, A., M. Cuenca-Estrella, A. Monzón, and J. L. Rodriguez-Tudela. 2007. Prevalence and susceptibility testing of new species of Pseudallescheria and Scedosporium in a collection of clinical mold isolates. Antimicrob. Agents Chemother. 51:748-751. (Pubitemid 46185300)
3. Almyroudis, N. G., D. A. Sutton, A. W. Fothergill, M. G. Rinaldi, and S. Kusne. 2007. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob. Agents Chemother. 51:2587-2590. (Pubitemid 47047341)
4. Cuenca-Estrella, M., A. Gomez-Lopez, E. Mellado, M. J. Buitrago, A. Mon-zón, and J. L. Rodriguez-Tudela. 2006. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clin-ical isolates of yeasts and filamentous fungi. Antimicrob. Agents Chemother. 50:917-921. (Pubitemid 43327795)
5. Dannaoui, E., J. Meletiadis, J. W. Mouton, J. F. Meis, and P. E. Venveij. 2003. In vitro susceptibilities of zygomycetes to conventional and new anti-fungals. J. Antimicrob. Chemother. 51:45-52. (Pubitemid 36163826)
6. Dannaoui, E., J. W. Mouton, J. F. G. M. Meis, and P. E. Verwefj. 2002. Efficacy of antifungal therapy in a nonneutropenic murine model of zygo-mycosis. Antimicrob. Agents Chemother. 46:1953-1959. (Pubitemid 34535220)
7. de Hoog, G., J. Guarro, C. S. Tan, R. G. F. Wintermans, and J. Gene. 1995. Hyphomycetes, p. 380-1007. In G. S. de Hoog and J. Guarro (ed.), Adas of clinical fungi. Centraalbureau voor Schimmelcultures, Utrech, The Nether-lands.
8. Gómez-López, A., M. Cuenca-Estrella, A. Monzón, and J. L. Rodriguez-Tudela. 2001. In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole. J. Antimicrob. Chemother. 48:919-921. (Pubitemid 33735332)
9. Honda, A., K. Kamel, H. Unno, K. Hiroshima, T. Kuriyama, and M. Miyaji. 1998. A murine model of zygomycosis by Cunninghamella bertholletiae. My-copathologia 144:141-146. (Pubitemid 29478198)
10. Imhof, A., S. A. Balajee, D. N. Fredricks, J. A. Englund, and K. A. Marr. 2004. Breakthrough fungal infections in stem cell transplant recipients re-ceiving voriconazole. Clin. Infect. Dis. 39:743-746. (Pubitemid 39180450)
11. Kontoyiannis, D. P., M. S. Lionakis, R. E. Lewis, G. Chamilos, M. Healy, C. Perego, et al. 2005. Zygomycosis in a tertiary-care cancer center in the era of /4íperjji7/wí-active antifungal therapy: a case-control observational study of 27 recent cases. J. Infect. Dis. 191:1350-1360. (Pubitemid 40503665)
12. Mosquera, J., P. A. Warn, J. L. Rodriguez-Tudela, and D. W. Denning. 2001. Treatment oiAbsidia corymbifera infection in mice with amphotericin B and itraconazole. J. Antimicrob. Chemother. 48:583-586. (Pubitemid 33040705)
13. Mullane, K., A. A. Toor, C. Kalnicky, T. Rodriguez, and J. Klein. 2007. Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections. Transpl. Infect. Dis. 9:89-96. (Pubitemid 46669087)
14. NCCLS/CLSI. 2005. Reference method for broth dilution antifungal suscep-tibility. Testing of filamentous fungi: approved standard document M38-A. Clinical and Laboratory Standards Institute, Wayne, PA.
15. Ortin, X., L. Escoda, A. Llórente, R. Rodriguez, S. Martinez, J. Boixadera, et al. 2004. Cunninghamella bertholletiae infection (mucormycosis) in a pa-tient with acute T-cell lymphoblastic leukemia. Leuk. Lymphoma 45:617-620. (Pubitemid 38196049)
16. Perkhofer, S., M. Locher, M. Cuenca-Estrella, R. Ruchel, R. Wurzner, M. P. Dierich, et al. 2008. Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro. Antimicrob. Agents Chemother. 52:2636-2638. (Pubitemid 352761869)
17. Petrikkou, E., J. L. Rodriguez-Tudela, M. Cuenca-Estrella, A. Gomez, A. Molleja, and E. Mellado. 2001. Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans. J. Clin. Microbiol. 39:1345-1347. (Pubitemid 32275433)
18. Prabhu, R. M., and R. Patel. 2004. Mucormycosis and entomophthoramy- cosis: a review of the clinical manifestations, diagnosis and treatment. Clin. Microbiol. Infect. 10(Suppl. l):31-47. 19. Ribes, J. A., C. L. Vanover-Sams, and D. J. Baker. 2000. Zygomycetes in human disease. Clin. Microbiol. Rev. 13:236-301. (Pubitemid 38379950)
19. Ribes, J.A., C. L. Vanover-Sams, and D. J. Baker. 2000 Zygomycetes in human disease. Clin. Microbiol. Rev. 13:236-301 (Pubitemid 30205427)
20. Roden, M. M., T. E. Zaoutis, W. L. Buchanan, T. A. Knudsen, T. A. Sarkisova, R. L. Schaufele, et al. 2005. Epidemiology and outcome of zygo-mycosis: a review of 929 reported cases. Clin. Infect. Dis. 41:634-653. (Pubitemid 41170352)
21. Rodriguez-Tudela, J. L., L. Alcazar-Fuoli, A. Alastruey-Izquierdo, A. Mon-zón, E. Mellado, and M. Cuenca-Estrella. 2007. Time of incubation for antifungal susceptibility testing of Aspergillus fumigatus: can MIC values be obtained at 24 hours? Antimicrob. Agents Chemother. 51:4502-4504.
22. Rodriguez-Tudela, J. L., E. Chryssanthou, E. Petrikkou, J. Mosquera, D. W. Denning, and M. Cuenca-Estrella. 2003. Interlaboratory evaluation of he-matocytometer method of inoculum preparation for testing antifungal sus-ceptibilities of filamentous fungi. J. Clin. Microbiol. 41:5236-5237. (Pubitemid 37429948)
23. Rodriquez-Tudela, J. L., J. P. Donnelly, M. C. Arendrup, S. Arikan, F. Barchiesi, J. Bille, et al., on behalf of the Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicro-bial Susceptibility Testing. 2008. EUCAST technical note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin. Microbiol. Infect. 14: 982-984.
24. Rogers, T. R. 2008. Treatment of zygomycosis: current and new options. J. Antimicrob. Chemother. 61(Suppl. I):i35-i40. (Pubitemid 350246389)
25. Singh, J., D. Rimek, and R. Kappe. 2005. In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method. Mycoses 48:246-250. (Pubitemid 26229753)
26. Siwek, G. T., K. J. Dodgson, M. Magalhães-Silverman, L. A. Bartelt, S. B. Kilborn, P. L. Hoth, et ai. 2004. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin. Infect. Dis. 39:584-587. (Pubitemid 39120940)
27. Trifllio, S. M., C. L. Bennett, P. R. Yarnold, J. M. McKoy, J. Parada, J. Mehta, et al. 2007. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hemato-poietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 39:425-429. (Pubitemid 46487308)
28. Voigt, K., E. Cigelnik, and K. O'Donnell. 1999. Fhylogeny and FCR identi-fication of clinically important zygomycetes based on nuclear ribosomal-DNA sequence data. J. Clin. Microbiol. 37:3957-3964.
29. Zeilender, S., D. Drenning, F. L. Glauser, and D. Bechard. 1990. Fatal Cunninghamella bertholletiae infection in an immunocompetent patient. Chest 97:1482-1483. (Pubitemid 20185704)
30. Zhang, R., J. W. Zhang, and H. M. Szerlip. 2002. Endocarditis and hemor-rhagic stroke caused by Cunninghamella bertholletiae infection after kidney transplantation. Am. J. Kidney Dis. 40:842-846.